The reduction in price target by RBC Capital from $20 to $13 suggests a bearish outlook on GoHealth's stock in the short term. This adjustment reflects the analyst's revised expectations on the company's future performance, which could lead to a negative sentiment among investors and potentially result in a decrease in the stock price.